Genomics

Dataset Information

0

A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (ATAC-Seq)


ABSTRACT: Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive and largely incurable hematologic malignancy originating from plasmacytoid dendritic cells (pDCs). Using RNA interference screening, we identified the E-box transcription factor TCF4 as a master regulator of the BPDCN oncogenic program. TCF4 served as a faithful diagnostic marker of BPDCN, and its downregulation caused the loss of the BPDCN-specific expression program and apoptosis. High-throughput drug screening revealed that bromodomain and extra-terminal domain inhibitors (BETi's) induce BPDCN apoptosis, which was attributable to disruption of the TCF4-dependent transcriptional network and loss of BPDCN-specific super-enhancers. BETi's retarded the growth of BPDCN xenografts, supporting their clinical evaluation in this recalcitrant malignancy.

ORGANISM(S): Homo sapiens

PROVIDER: GSE84623 | GEO | 2016/11/15

SECONDARY ACCESSION(S): PRJNA330681

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2016-11-15 | GSE84471 | GEO
2016-11-15 | GSE75650 | GEO
2016-11-15 | GSE76147 | GEO
2024-02-11 | GSE230487 | GEO
2022-04-05 | GSE200113 | GEO
2021-09-17 | GSE184293 | GEO
2014-10-03 | E-GEOD-62014 | biostudies-arrayexpress
| EGAS00001003660 | EGA
| EGAD00010001727 | EGA
| EGAS00001006166 | EGA